Thousands of Australians patients with blood pressure face higher out-of-pocket costs after the Department of Health moved to delist one of the most popular anti-hypertensives on the PBS over a pricing dispute.
Latest Video
New Stories
-
Minister confirms expanded funded access to GSKs shingles vaccine
September 23, 2024 - - Latest News -
Logical to gather more information because of the legal liability for decisions
September 23, 2024 - - Latest News -
Parliament backs government move to clarify pricing legislation
September 23, 2024 - - Latest News -
The HTA Review - 'Red Flag' number five of five
September 20, 2024 - - Latest News -
A way forward is an opportunity to avoid the pitfalls of previous processes
September 20, 2024 - - Latest News -
The Dispatched 'Week in Review' - 20 September
September 19, 2024 - - Podcast -
Clear political leadership delivers green shoots in New Zealand
September 18, 2024 - - Latest News